Search

everythinglearnresearchcommunity

for

Search:↓

Diabetic patients need tailored cosmetic treatments for skin aging, with new therapies showing promise.

Current tools inadequately measure quality of life in children with alopecia areata, needing better instruments.

Cancer patients in sub-Saharan Africa face significant challenges during chemotherapy, highlighting the need for better patient care and support.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

Understanding patients' emotions can help oncologists improve communication and support during treatment decisions.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

Celiac patients may have kidney function risks due to increased urea and creatinine and decreased magnesium, zinc, and vitamin C.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Acne patients have lower enzyme activity, suggesting oxidative stress may contribute to acne.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Reinfection patients had more physical complications, while initial infection patients had more mental health issues.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

Elderly patients often have skin issues like itching and hair loss, and early treatment can improve their quality of life.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

PCA patients have more harmful bacteria and antibiotic resistance, needing specific testing for treatment.

PCOS patients, especially obese ones, often lack vitamin D and may need supplements and lifestyle changes.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Low-dose oral minoxidil is generally safe for hypertensive patients with hair loss.

Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.

Psoriasis patients are more likely to experience maladaptive daydreaming.

Many patients with hidradenitis suppurativa also have severe acne and pilonidal cysts, often linked to other health problems.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

PCOS patients have more central body fat, which can be effectively measured using DEXA.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Refugee patients face long wait times for dermatology care, worsening health disparities.